Results: 1-25 | 26-39

Table of contents of journal: *Cancer biotherapy

Results: 1-25/39

Authors: OLDHAM RK
Citation: Rk. Oldham, DISCLOSURE IN RESEARCH FUNDING, Cancer biotherapy, 8(4), 1993, pp. 273-274

Authors: JONES M PHILIP T PALMER P VONDERMAASE H VINKE J ELSON P FRANKS CR SELBY P
Citation: M. Jones et al., THE IMPACT OF INTERLEUKIN-2 ON SURVIVAL IN RENAL-CANCER - A MULTIVARIATE-ANALYSIS, Cancer biotherapy, 8(4), 1993, pp. 275-288

Authors: ATZPODIEN J KIRCHNER H DEMULDER P BODENSTEIN H OLIVER T PALMER PA FRANKS CR POLIWODA H
Citation: J. Atzpodien et al., SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA - RESULTS OF A MULTICENTER PHASE-II STUDY, Cancer biotherapy, 8(4), 1993, pp. 289-300

Authors: HANNINEN EL FENNER M KIRCHNER H DECKERT M DUENSING S MENZEL T POLIWODA H ATZPODIEN J
Citation: El. Hanninen et al., LIMITED EFFICACY OF INTERFERON-ALPHA AND VINBLASTINE AS 2ND LINE BIOCHEMOTHERAPY REGIMEN IN PATIENTS WITH PROGRESSIVE METASTATIC RENAL-CELLCARCINOMA, Cancer biotherapy, 8(4), 1993, pp. 301-306

Authors: FUJIMAKI W ITOH K AN T GANO JB ROSS MI MANSFIELD PF BALCH CM AUGUSTUS LB KARKEVITCH DD JOHNSTON D FIDLER IJ KLEINERMAN ES
Citation: W. Fujimaki et al., CYTOKINE PRODUCTION AND IMMUNE CELL ACTIVATION IN MELANOMA PATIENTS TREATED WITH LIPOSOMAL MURAMYL TRIPEPTIDE (CGP-19835A LIPID), Cancer biotherapy, 8(4), 1993, pp. 307-318

Authors: NAKAJIMA I OZAKI M JINNAI H SHILAYAMA Y HIROHATA T OKUNO K YASUTOMI M
Citation: I. Nakajima et al., ENHANCED ACTIVITY AGAINST SYNGENEIC MURINE TUMORS BY INTRASPLENIC INJECTION OF RECOMBINANT INTERLEUKIN-2 (IL-2) AND INTERLEUKIN-1 (IL-1), Cancer biotherapy, 8(4), 1993, pp. 319-326

Authors: XIANG J QI YM LUO XM LIU EW
Citation: J. Xiang et al., RECOMBINANT BIFUNCTIONAL MOLECULE FV IFN-GAMMA POSSESSES THE ANTITUMOR FV AS WELL AS THE GAMMA-INTERFERON ACTIVITIES/, Cancer biotherapy, 8(4), 1993, pp. 327-337

Authors: NAIR SC PANIKKAR KR PARTHOD RK
Citation: Sc. Nair et al., PROTECTIVE EFFECTS OF CROCETIN ON THE BLADDER TOXICITY INDUCED BY CYCLOPHOSPHAMIDE, Cancer biotherapy, 8(4), 1993, pp. 339-344

Authors: LOVQVIST A LINDSTROM A CARLSSON J
Citation: A. Lovqvist et al., BINDING, INTERNALIZATION AND EXCRETION OF TGF-ALPHA-DEXTRAN ASSOCIATED RADIOACTIVITY IN CULTURED HUMAN GLIOMA-CELLS, Cancer biotherapy, 8(4), 1993, pp. 345-356

Authors: OLDHAM RK
Citation: Rk. Oldham, WHATS THE SCORE, Cancer biotherapy, 8(3), 1993, pp. 187-188

Authors: HANNIGAN BM BARNETT YA ARMSTRONG DBA MCKELVEYMARTIN VJ MCKENNA PG
Citation: Bm. Hannigan et al., THYMIDINE KINASES - THE ENZYMES AND THEIR CLINICAL USEFULNESS, Cancer biotherapy, 8(3), 1993, pp. 189-197

Authors: MENZEL T SCHOMBURG A KORFER A HADAM M MEFFERT M DALLMANN I CASPER S KIRCHNER H POLIWODA H ATZPODIEN J
Citation: T. Menzel et al., CLINICAL AND PRECLINICAL EVALUATION OF RECOMBINANT PEG-IL-2 IN HUMAN, Cancer biotherapy, 8(3), 1993, pp. 199-212

Authors: OHNISHI H OKUNO K YASUTOMI M
Citation: H. Ohnishi et al., SUCCESSFUL IN-VIVO GENERATION OF CANINE LYMPHOKINE-ACTIVATED KILLER-CELLS BY CONTINUOUS RECOMBINANT INTERLEUKIN-2 INFUSION THROUGH THE SPLENIC ARTERY, Cancer biotherapy, 8(3), 1993, pp. 213-222

Authors: GOMELLA LG MCGINNIS DE LATTIME EC BUTLER K BALTISH M THOMPSON I MARSHALL ME
Citation: Lg. Gomella et al., TREATMENT OF TRANSITIONAL-CELL CARCINOMA OF THE BLADDER WITH INTRAVESICAL INTERLEUKIN-2 - A PILOT-STUDY, Cancer biotherapy, 8(3), 1993, pp. 223-227

Authors: MERTENS WC BRAMWELL VHC BANERJEE D GWADRYSRIDHAR F ALMUTTER N PARHAR RS LALA PK
Citation: Wc. Mertens et al., SUSTAINED ORAL INDOMETHACIN AND RANITIDINE WITH INTERMITTENT CONTINUOUS-INFUSION INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Cancer biotherapy, 8(3), 1993, pp. 229-233

Authors: KRISHNAVENI L GHOSH S ADWANKAR M
Citation: L. Krishnaveni et al., CHROMOSOMAL CHANGES DURING THE ACQUISITION OF RESISTANCE TO ADRIAMYCIN IN TUMORIGENIC HUMAN SYNOVIAL-CELLS, Cancer biotherapy, 8(3), 1993, pp. 235-239

Authors: LEE AK HESTER RB COGGIN JH GOTTLIEB SF
Citation: Ak. Lee et al., INCREASED OXYGEN-TENSIONS MODULATE THE CELLULAR COMPOSITION OF THE ADAPTIVE IMMUNE-SYSTEM IN BALB C MICE/, Cancer biotherapy, 8(3), 1993, pp. 241-252

Authors: XIANG J LIU EW DELBAERE LTJ CHEN ZN LUO XM QI YM RATHGEBER C
Citation: J. Xiang et al., THE TYROSINE RESIDUE AT POSITION-97 IN THE V(H)-CDR3-REGION OF A MOUSE-HUMAN CHIMERIC ANTI-COLORECTAL CARCINOMA ANTIBODY CONTRIBUTES HYDROGEN-BONDING TO THE TAG72-ANTIGEN, Cancer biotherapy, 8(3), 1993, pp. 253-262

Authors: LI L JIAO LP LAU BHS
Citation: L. Li et al., PROTECTIVE EFFECT OF GYPENOSIDES AGAINST OXIDATIVE STRESS IN PHAGOCYTES, VASCULAR ENDOTHELIAL-CELLS AND LIVER-MICROSOMES, Cancer biotherapy, 8(3), 1993, pp. 263-272

Authors: OLDHAM RK
Citation: Rk. Oldham, FUNDAMENTALLY FLAWED (REPRINTED FROM MOLECULAR BIOTHERAPY, VOL 1, PG 58-60, 1993), Cancer biotherapy, 8(2), 1993, pp. 111-114

Authors: CHASEN MR FALKSON G
Citation: Mr. Chasen et G. Falkson, LEUKEMIA AFTER CHEMOTHERAPY FOR CANCER, Cancer biotherapy, 8(2), 1993, pp. 115-122

Authors: PALMER PA ATZPODIEN J PHILIP T NEGRIER S KIRCHNER H VONDERMAASE H GEERTSEN P EVERS P LORIAUX E OSKAM R ROEST G VINKE J FRANKS CR
Citation: Pa. Palmer et al., A COMPARISON OF 2 MODES OF ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 - CONTINUOUS INTRAVENOUS-INFUSION ALONE VERSUS SUBCUTANEOUS ADMINISTRATION PLUS INTERFERON-ALPHA IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Cancer biotherapy, 8(2), 1993, pp. 123-136

Authors: SMITH BW KURZMAN ID SCHULTZ KT CZUPRYNSKI CJ MACEWEN EG
Citation: Bw. Smith et al., MURAMYL PEPTIDES AUGMENT THE IN-VITRO AND IN-VIVO CYTOSTATIC ACTIVITYOF CANINE PLASTIC-ADHERENT MONONUCLEAR-CELLS AGAINST CANINE OSTEOSARCOMA CELLS, Cancer biotherapy, 8(2), 1993, pp. 137-144

Authors: LINDSTROM A CARLSSON J
Citation: A. Lindstrom et J. Carlsson, PENETRATION AND BINDING OF EPIDERMAL GROWTH FACTOR-DEXTRAN CONJUGATESIN SPHEROIDS OF HUMAN GLIOMA ORIGIN, Cancer biotherapy, 8(2), 1993, pp. 145-158

Authors: GRIDLEY DS SURA SS UHM JR LIN CH KETTERING JD
Citation: Ds. Gridley et al., EFFECTS OF ANTI-TRANSFORMING GROWTH-FACTOR-BETA ANTIBODY AND INTERLEUKIN-2 IN TUMOR-BEARING MICE, Cancer biotherapy, 8(2), 1993, pp. 159-170
Risultati: 1-25 | 26-39